1. Home
  2. TENX vs SRFM Comparison

TENX vs SRFM Comparison

Compare TENX & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • SRFM
  • Stock Information
  • Founded
  • TENX 1967
  • SRFM 2011
  • Country
  • TENX United States
  • SRFM United States
  • Employees
  • TENX N/A
  • SRFM N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • SRFM Transportation Services
  • Sector
  • TENX Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • TENX 21.6M
  • SRFM 58.2M
  • IPO Year
  • TENX N/A
  • SRFM 2023
  • Fundamental
  • Price
  • TENX $5.81
  • SRFM $3.95
  • Analyst Decision
  • TENX Strong Buy
  • SRFM Buy
  • Analyst Count
  • TENX 3
  • SRFM 4
  • Target Price
  • TENX $16.00
  • SRFM $5.56
  • AVG Volume (30 Days)
  • TENX 42.1K
  • SRFM 13.7M
  • Earning Date
  • TENX 08-12-2025
  • SRFM 08-13-2025
  • Dividend Yield
  • TENX N/A
  • SRFM N/A
  • EPS Growth
  • TENX N/A
  • SRFM N/A
  • EPS
  • TENX N/A
  • SRFM N/A
  • Revenue
  • TENX N/A
  • SRFM $112,307,000.00
  • Revenue This Year
  • TENX N/A
  • SRFM N/A
  • Revenue Next Year
  • TENX N/A
  • SRFM $54.32
  • P/E Ratio
  • TENX N/A
  • SRFM N/A
  • Revenue Growth
  • TENX N/A
  • SRFM 31.17
  • 52 Week Low
  • TENX $2.80
  • SRFM $0.90
  • 52 Week High
  • TENX $7.89
  • SRFM $6.72
  • Technical
  • Relative Strength Index (RSI)
  • TENX 49.28
  • SRFM 64.64
  • Support Level
  • TENX $5.66
  • SRFM $3.30
  • Resistance Level
  • TENX $6.00
  • SRFM $4.16
  • Average True Range (ATR)
  • TENX 0.53
  • SRFM 0.79
  • MACD
  • TENX -0.01
  • SRFM 0.17
  • Stochastic Oscillator
  • TENX 33.33
  • SRFM 61.32

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: